| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(74)90637-8 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0002934374906378?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0002934374906378?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 4596651 |
| P2093 | author name string | A. I. Arieff | |
| C. A. Chidsey | |||
| P2860 | cites work | RENAL CIRCULATION IN CIRRHOSIS: OBSERVATIONS BASED ON CATHETERIZATION OF THE RENAL VEIN. | Q33956597 |
| Renal failure in Laennec's cirrhosis. II. Simultaneous determination of cardiac output and renal hemodynamics | Q34024784 | ||
| Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease | Q34221529 | ||
| Electrolyte and circulatory changes in terminal liver failure | Q34240199 | ||
| THE KIDNEY IN CIRRHOSIS. I. CLINICAL AND BIOCHEMICAL FEATURES OF AZOTEMIA IN HEPATIC FAILURE. | Q34256654 | ||
| Control of phosphate excretion in uremic man | Q34277981 | ||
| Effect of chronic bile duct obstruction on renal handling of salt and water | Q34492690 | ||
| An explanation for and experimental correction of the abnormal water diuresis in cirrhosis | Q35564209 | ||
| Cirrhotic (hepatic) lobular glomerulonephritis. Correlation of ultrastructural and clinical features | Q36051498 | ||
| Renal effects of prostaglandin A1 in patients with essential hypertension | Q38486551 | ||
| Sodium metabolism | Q39891144 | ||
| Salt retention in cirrhosis of the liver | Q40979415 | ||
| Renal and intrarenal blood-flow in cirrhosis of the liver | Q43904893 | ||
| Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin | Q44484703 | ||
| Combined Ascitic-Fluid and Furosemide Infusion in the Management of Ascites | Q45078689 | ||
| Renal failure in the patient with cirrhosis. The role of active vasoconstriction | Q48905954 | ||
| Effects of prostaglandins E 1 , A 1 , and F 2 on renal handling of salt and water. | Q52981614 | ||
| Hemodynamic and Renal Effects of a Prostaglandin, PGA1, in Subjects with Essential Hypertension | Q54683052 | ||
| Renal function changes in cirrhosis of the liver. A prospective study | Q69973774 | ||
| Renal vasodilator therapy in the hepatorenal syndrome | Q70995105 | ||
| Renal response to saline load in experimental liver disease | Q71616214 | ||
| Prognosis in Acute Liver Disease of the Alcoholic Patient | Q72846978 | ||
| Circulatory changes in chronic liver disease | Q74845802 | ||
| THE KIDNEY IN CIRRHOSIS. II. DISORDERS OF RENAL FUNCTION | Q76748394 | ||
| SPONTANEOUS RECOVERY FROM THE HEPATORENAL SYNDROME: REPORT OF FOUR CASES | Q78288293 | ||
| RENAL LESIONS IN HEPATIC DISEASE: A STUDY BASED ON KIDNEY BIOPSIES | Q78386464 | ||
| RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS | Q78465518 | ||
| RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. II. FACTORS INFLUENCING MAXIMAL URINARY FLOW RATE | Q78465522 | ||
| Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features | Q78856345 | ||
| The renal extraction of para-aminohippurate in normal persons and in patients with diseased kidneys | Q79154558 | ||
| Clinical Report on Hydro-Peritoneum, based on an analysis of forty-six cases | Q110502542 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 695-703 | |
| P577 | publication date | 1974-05-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Renal function in cirrhosis and the effects of prostaglandin A | |
| Renal function in cirrhosis and the effects of prostaglandin A1 | |||
| P478 | volume | 56 |
| Q33532744 | A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance |
| Q41621372 | Angiotensin-induced sodium excretion patterns in cirrhosis: role of renal prostaglandins |
| Q40904311 | Combined use of dopamine and prostaglandin A1 in patients with acute renal failure and hepatorenal syndrome |
| Q70451469 | Effect of prostaglandin inhibition by indomethacin on renal function in alcoholic versus non-alcoholic cirrhotic patients |
| Q40164045 | Hepatic nephropathy, related to haemodynamics |
| Q70916883 | Hepato-renal syndrome (author's transl) |
| Q34170377 | Hepatorenal failure |
| Q70616909 | Hepatorenal syndrome |
| Q41047621 | Hepatorenal syndrome: a disease mediated by the intrarenal action of renin |
| Q61577038 | Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure |
| Q72450409 | Pharmacologic agents used in the management of acute renal failure |
| Q70058348 | Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation |
| Q41024576 | Renal and Cerebral Blood Flow in Experimental Liver Failure in the Pig |
| Q55066872 | Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. |
| Q45171475 | Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function |
| Q39679227 | Renal eicosanoids as determinants of renal function in liver disease |
| Q70606793 | Renal insufficiency associated with nonsteroidal anti-inflammatory agents |
| Q35946476 | Reversible renal failure in the nephrotic syndrome |
| Q36198133 | The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review |
| Q71028023 | The hepatorenal syndrome |
| Q38812692 | Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine |
Search more.